Taken together, it is obvious that CSD and Laplacian measures can aid in identifying and understanding the brain lesions in some of the neurological conditions and thus serve as powerful and sensitive measures of cortical activation. However, as is the case with many other clinical domains, several neurological conditions, including epilepsy and specific brain lesions, need more CSD studies in order to elicit and establish functional electrophysiological markers in these conditions.
